Brain Cancer
Bifrontal Glioblastoma Multiforme
Male, 26 years
Patient Internal 708782583
ICD-10 code
C71.9 Malignant neoplasm: Brain, Unspecified
Diagnosis (Incl. Metastases/Stage) and Year
December 2014
Bifrontal Glioblastoma Multiforme Midline Glioma, WHO Grade 4, TP53 (+) and IDH1(+) Gene Mutations.
Previous Treatment
Radiation Therapy, Chemotherapy (Temozolomide), Target Therapy (Ipatasertib+Atezolizumab).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~14 months from diagnosis.
Treatment Provided
Autologous DCV (3 doses) over a period of 1 month.
Patient Survival/Condition and Year
Date of Review: 01/12/2023
The patient survived for 6 years and 5 months after diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy, Chemotherapies and Target Therapies, extended patient survival by an estimate of around 5 years.
